Emkay Global has reiterated BUY recommendation on HDB Financial Services, maintaining confidence in the company’s medium-term growth narrative even as operational challenges marred the Q2FY26 outco

In its latest research, Prabhudas Lilladher has issued a “HOLD” recommendation for JSW Steel, reflecting a narrative of impressive volume growth and resilient operating performance amidst softer st

Emkay Global has reaffirmed a BUY rating on HDFC Life Insurance, assigning a September 2026 target price of Rs 850.

In its latest research, Choice Equity Broking maintains BUY recommendation on technology major Infosys, revising the target price to Rs 1,810—implying a potential upside of 25.7% from current level

India’s fintech revolution has matured into a trillion-dollar opportunity by 2030, reshaping how hundreds of millions manage, borrow, invest, and insure their finances.

India’s biotechnology industry, one of the fastest-expanding sectors globally, is blazing new trails across healthcare, pharmaceuticals, and sustainability.